NervGen Pharma Corp. (NGEN) Ownership
NGEN ownership summary
as of October 18, 2026- Institutions
- 11.2% of shares outstanding
- Insiders
- 15.63% of shares outstanding
- Shares outstanding
- 107.5M
- Float
- 95.3M shares available to trade
- Short interest
- — 5.8M shares short
- Days to cover
- 10.82 short interest up 6.2% vs prior month
- Institutions 11.24%
- Insiders 15.63%
- Other investors 73.13%
NGEN top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Empery Asset Management, LP | 3.72% | 4.0M | $6.4M | +4.0M (0.0%) | June 30, 2026 |
| 2 | Rock Springs Capital Management LP | 1.12% | 1.2M | $1.9M | +1.2M (0.0%) | June 30, 2026 |
| 3 | Dafna Capital Management LLC | 0.98% | 1.1M | $1.7M | +1.1M (0.0%) | June 30, 2026 |
| 4 | Ghisallo Capital Management LLC | 0.93% | 1.0M | $1.6M | +1.0M (0.0%) | June 30, 2026 |
| 5 | Armistice Capital, LLC | 0.63% | 678K | $1.1M | +678,000 (0.0%) | June 30, 2026 |
| 6 | LMR Partners LLP | 0.56% | 600K | $954,000 | +600,000 (0.0%) | June 30, 2026 |
| 7 | Marshall Wace Asset Management Ltd | 0.41% | 436K | $693,180 | +235,603 (+117.6%) | June 30, 2026 |
| 8 | UBS Group AG | 0.35% | 380K | $603,764 | +318,209 (+517.3%) | June 30, 2026 |
| 9 | Stonepine Capital Management Llc | 0.25% | 272K | $431,968 | +271,678 (0.0%) | June 30, 2026 |
| 10 | Jane Street Group LLC | 0.25% | 271K | $430,492 | +270,750 (0.0%) | June 30, 2026 |
| 11 | Woodline Partners LP | 0.23% | 250K | $398,295 | +250,500 (0.0%) | June 30, 2026 |
| 12 | PFG Investments, LLC | 0.20% | 218K | $345,825 | +16,500 (+8.2%) | June 30, 2026 |
| 13 | Bank of America Corp | 0.17% | 186K | $296,058 | −14,456 (−7.2%) | June 30, 2026 |
| 14 | Royal Bank of Canada | 0.16% | 176K | $279,959 | +4,114 (+2.4%) | June 30, 2026 |
| 15 | Quadrature Capital Limited | 0.13% | 135K | $213,884 | +134,518 (0.0%) | June 30, 2026 |
| 16 | Bank of Montreal | 0.07% | 78K | $124,646 | +15,494 (+24.6%) | June 30, 2026 |
| 17 | BMO Capital Markets Corp. | 0.07% | 78K | $124,646 | +15,494 (+24.6%) | June 30, 2026 |
| 18 | Integrated Wealth Concepts LLC | 0.07% | 74K | $118,002 | −12,600 (−14.5%) | June 30, 2026 |
| 19 | CapTrust Financial Advisors | 0.06% | 64K | $102,433 | +2,056 (+3.3%) | June 30, 2026 |
| 20 | Geode Capital Management, LLC | 0.05% | 58K | $92,284 | +58,040 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 18 holders added 10.1M shares and 2 cut 27K.
NGEN top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 0.06% | 67K | $107,244 | — | August 31, 2026 |
| 2 | State Street® SPDR® S&P® Intl Sm Cp ETF | 0.06% | 61K | $97,467 | — | September 30, 2026 |
| 3 | iShares Neuroscience and Healthcare ETF | 0.01% | 8,257 | $13,129 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
NGEN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns NGEN
Institutional investors own 11.2% of NervGen Pharma's shares and insiders 15.63%. The largest holder is Empery Asset Management, LP with 3.72% of the shares (4.0M), as of June 30, 2026. Among the top 20 institutions, 18 added shares and 2 reduced their stake in the latest filings. The share count rose 165.9% since 2017.
Related: NGEN analyst forecast, NGEN key metrics. See the NGEN stock overview for the latest quote and news.
NGEN ownership FAQ
Who owns the most NervGen Pharma stock?
The largest shareholders of NervGen Pharma are Empery Asset Management, LP (3.72%), Rock Springs Capital Management LP (1.12%), Dafna Capital Management LLC (0.98%), Ghisallo Capital Management LLC (0.93%), Armistice Capital, LLC (0.63%).
What percentage of NervGen Pharma is owned by institutions?
Institutions hold 11.2% of NervGen Pharma's shares outstanding; insiders hold 15.63%.
Which funds own NervGen Pharma?
The largest fund holders of NervGen Pharma are Fidelity Nasdaq Composite Index (0.06%), State Street® SPDR® S&P® Intl Sm Cp ETF (0.06%), iShares Neuroscience and Healthcare ETF (0.01%).
How many shares of NervGen Pharma are outstanding?
NervGen Pharma has 107.5M shares outstanding, of which 95.3M are in the public float.